Skip to main content
TipRanks
Go Ultimate75% OFF

Oncopeptides AB (ONCO) Revenue

11 Followers

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 28.45M in the quarter ending Sep 30, 2026, with -8.51%. This bring the company's revenue in the last twelve months to 103.50M, Increased 8.65%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.

Revenue (ttm)
103.50M
Revenue Growth
65.37%
P/S Ratio
10.26
Revenue/Employee
SEK 1,001,662
Employees
71
Market Cap
SEK 729.43M

Revenue Chart

Oncopeptides AB Revenue - Annual

025M50M75M100M125M118.30M8.36M35.22M31.65M71.12M201720182019202020212022202320242025
Revenue History
Download to Excel
SE:ONCO revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202571.12M39.47M124.72%
Dec 31, 202431.65M-3.57M-10.14%
Dec 31, 202335.22M26.86M321.54%
Dec 31, 20228.36M-109.94M-92.94%
Dec 31, 2021118.30M118.30M―
Dec 31, 20200.000.00―
Dec 31, 20190.000.00―
Dec 31, 20180.000.00―
Dec 31, 20170.00――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
SE:ONCO103.50M
SE:ATORX283.00K
SE:BINV39.98M
SE:IMMU0.00
SE:CANTA317.31M
SE:SPRINT133.91M